Travis Parigi, CEO of LiquidFrameworks, is excited about the new doors that have been opened for his company. Courtesy of LiquidFrameworks

Travis Parigi has built his software within his own company for about 14 years. Now, he's in a position to further develop his product at a faster rate.

In January, LiquidFrameworks entered into a partnership with private equity firm, Luminate Capital. The new financial partner has opened doors for Parigi and LiquidFrameworks — including putting merger and acquisition activity on the table.

"I have historically written stuff from the ground up, and we're going to continue to do that, but we want to give our customers more than that," Parigi tells InnovationMap. "And I've never had the opportunity to go out and strategically target opportunities where it makes sense to compliment the product. And I think that's going to be a very exciting thing to do."

Parigi, founder and CEO, tells InnovationMap about how his company has transformed over the years — and especially over the past several months with its new financial backer.

InnovationMap: How did you get your start in software development?

Travis Parigi: I've been building software since I was a very young kid, actually. I started writing software for companies at a very early age and realized that I really, really enjoyed it. And so when I say young, I'm talking in grade school and high school. And I really found that it was rewarding and I enjoyed meeting the requirements that people gave me. From the very early days, I knew I wanted to start a software company, but I really wasn't sure exactly what it would do. I went to work in the consulting industry right after graduating from A&M University with a degree in computer science and engineering and was building software for variety of different companies that were their clients and started to get some exposure to the energy industry.

Then in the late 1990s, the company I was at was going through some financial struggles, and it became an opportune time for me to start my own consulting company building software for companies. One client I had was Schlumberger, and I really started seeing this similar business problem related to collecting data at the well site. The workers in the field were working with paper and Excel. I thought it was a great opportunity to move people out of manual and into the digital world.

IM: Now, over a decade later, what role do you feel LiquidFrameworks plays in the industry?

TP: We play a role of standardizing the datasets that our clients are working with as it relates to the quote to cash process. So, specifically around their pricing data and their catalog data. We're standardizing that data and we're getting it into form and a shape that allows them to easily keep it up to date and easily syndicated changes related to that data out to not only other offices and districts, but also field crew that may be occasionally connected to the network.

With that data, we can do all sorts of things that end up benefiting the customer — like using it to create field tickets, invoices, work orders, safety forms, quotes, and all sorts of transactions that really need to be based upon one homogenous set of data that standardize, that isn't floating around in various documents.

IM: Where does the artificial intelligence LiquidFrameworks has developed come into play?

TP: We're taking it one step further, and once they finished those transactions, they end up with not just the reference data as it relates to pricing, but also the transactional data, we can use that data to infer the best way to quote or price new services in the future that will position the company and the best possible place to win the deals that they're quoting and bidding against. We're using different types of artificial intelligence algorithms to do that.

Nowadays, companies like us have at our disposal tools in the AI world — specifically in the machine learning world — that we just didn't have when I started the company. Fourteen years ago when I started the business, cloud computing in 2005 was not nearly as ubiquitous as it is today. And it wasn't as widely accepted and it certainly wasn't as widely accepted as it is in the energy industry today.

IM: What kind of clients are you working with?

TP: We're targeting three different industries. The upstream oil and gas service provider market, the downstream service provider market, and the emergency response service provider market. On the upstream side, they are companies doing work at the well site, and in downstream, they are companies doing work at the refineries.

IM: As automation and cloud technology is being more adapted within oil and gas, what technologies are now on your radar?

TP: In the beginning, we spent a lot of time educating our potential customers about cloud computing and about technologies that we had available. And now that a lot of that is so well received, it just means that we don't necessarily have to focus on that anymore. We can focus really on what really brings ROI to the customers that implement our product.

I keep a keen watch on a lot of the different technologies that are emerging out there. Blockchain is certainly one of them that we're looking at. I think there's some interesting things that we might be able to do with that as it relates to price book management, which is complex and varied. It could be that blockchain could end up providing a nice mechanism for both parties to independently have pricing data verified.

We're always keeping an eye on and doing work in artificial intelligence, specifically around machine learning. I think there's always new interesting stuff taking place there outside. I would say those two technologies are something that we're pretty pretty keen on.

IM: How has the transition into private equity been with your new partner in Silicon Valley-based Luminate Capital?

TP: We had a financial partner prior to Luminate Capital called Houston Ventures. Our managing partner there was a guy named Chip Davis. He was fantastic, and he helped us grow the business for about seven years. Eventually, we got to a point where we had grown to a level where I felt like, in order to do some things we wanted to do, we needed to establish a new financial partner. Private equity made the most sense for us, and it's really allowing us to do some things that we couldn't do with venture.

Over the years, we built out a fairly extensive roadmap, and my development team has worked very hard and diligently to fulfill those items on the roadmap. But our customer base has really grown significantly, and we've moved up into enterprise customers who have asked for a lot of things that we want to put into our product. And so our long range roadmap has grown. For these new features, we either need to build that ourselves in house, but, in some cases, there are some things that are tangential and complimentary to our product that other companies have already. So, it could make sense for us to go out and acquire those kinds of companies. And with Luminate, they provided us not only capital for us to do that, but equally as important, they provided an engine that we can facilitate from an M&A perspective to help us go and source those deals, find them, help assess them, and ultimately help acquire them and then integrate them into the overall platform.

IM: How has the partnership benefitted your company from a networking and opportunities perspective?

TP: Their portfolio of companies are similar to us and that they're are all enterprise software companies. They're not necessarily in the energy space, but they're all enterprise software companies. Being able to network with those companies has really been helpful. We didn't have a CFO prior to Luminate coming in. Part of the deal was that they said, "hey, we really would encourage and recommend that you get a CFO at this stage because you're growing and you need it." They provided some relationships there to in the form of recruiters to help us source the CFO. And we ended up sourcing a local CFO — Paul Marvin — who's absolutely fantastic.

IM: How has Houston been as a home base for you?

TP: Houston has been fantastic for LiquidFrameworks. I started the business based here and see no reason to change that. It is a fantastic market for us, both from a customer perspective as well as an employee perspective. The employee talent base in Houston is rich and deep. There's a lot of technical people here, and obviously there's a ton of energy companies.

IM: With all your operations being in Houston, do you see opportunities for other offices in the future?

TP: We have customers all over the world — a lot in Canada, so I could see an office there for sales and implementation. I would say that as we grow, expanding sales to other geographies is certainly something that will ultimately end up doing. It's just not something we've had to do yet.

IM: Are you planning on growing operations here?

TP: We've added a couple dozen people to the team just over the past few months, and we plan on doubling the staff by the end of next year.

------

Portions of this interview have been edited.

Houston-based LiquidFrameworks has been acquired by San Francisco-based Luminate Capital. Pexels

Houston startup exits to Bay Area private equity firm

Grand exit

A Houston startup has entered a deal with a San Francisco-based private equity firm, the companies announced on January 10. LiquidFrameworks, which provides cloud-based, mobile field operations management solutions to oil and gas, environmental, and industrial service companies, is now operating under Luminate Capital following the acquisition.

While not all the terms of the deal have been disclosed, Chip Davis, managing partner at Houston Ventures, says the transaction exceeded $50 million of PE investment from Luminate Capital. HV has been involved with LiquidFrameworks since 2012 and has invested a cumulative $6 million, Davis says, and brought in the company's current CEO and head of sales — both of who are still a part of the company's team.

"When we got involved, it was a very small company," says Davis. "As of today, it has enterprise customers of some of the largest oilfield services companies in the world."

According to the release, Hollie Haynes, Mark Pierce, and Sanjay Palakshappa from Luminate have joined the LiquidFrameworks board of directors. The PE fund's investment is a part of the recently closed $425 million Fund II.

"For over a decade, we have served field services companies by reducing revenue leakage, shortening cash collection cycles, and increasing overall operational efficiencies. We have streamlined the day-to-day operations for field services professionals and increased transparency across organizations by transforming previously paper- or excel-based workflows," says Travis Parigi, founder and COO of LiquidFrameworks, in the release.

"With a partner like Luminate Capital, we will continue to invest and develop product capabilities to better serve field services industries that have previously been overlooked by software innovation."

One of LiquidFrameworks' tools is FieldFX, which enhances companies' data accuracy and accelerates revenue capture and cash flow.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.